These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38299395)

  • 1. High-expression of FABP4 in Tubules is a Risk Factor for Poor Prognosis in DKD Patients.
    Huang Y; Cui X; Li Z; Yuan S; Han Y; Xu X; Fu X; Shi K; Zhang Z; Wei J; Xia S; Xiao Y; Xue S; Sun L; Liu H; Zhu X
    Curr Med Chem; 2024; 31(22):3436-3446. PubMed ID: 38299395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease.
    Yang W; Luo Y; Yang S; Zeng M; Zhang S; Liu J; Han Y; Liu Y; Zhu X; Wu H; Liu F; Sun L; Xiao L
    Clin Sci (Lond); 2018 Nov; 132(22):2407-2422. PubMed ID: 30348828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease.
    Li H; Shen Y; Yu Z; Huang Y; He T; Xiao T; Li Y; Xiong J; Zhao J
    Front Endocrinol (Lausanne); 2021; 12():731187. PubMed ID: 35095752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 6. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
    Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
    J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
    Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
    Wei J; Wang B; Shen FJ; Zhang TT; Duan Z; Zhou DM
    BMC Nephrol; 2022 Jul; 23(1):270. PubMed ID: 35896961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease.
    Jiang H; Shao X; Jia S; Qu L; Weng C; Shen X; Wang Y; Huang H; Wang Y; Wang C; Feng S; Wang M; Feng H; Geekiyanage S; Davidson AJ; Chen J
    Cell Physiol Biochem; 2019; 52(2):156-171. PubMed ID: 30816665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated ALOX12 in renal tissue predicts progression in diabetic kidney disease.
    Wang M; Wang J; Wang J; Wu Y; Qi X
    Ren Fail; 2024 Dec; 46(1):2313182. PubMed ID: 38345057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
    Zhang M; Zhao B; Xie J; Liang Y; Yang Z
    Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease.
    Xiao X; Zhang J; Ji S; Qin C; Wu Y; Zou Y; Yang J; Zhao Y; Yang Q; Liu F
    Front Endocrinol (Lausanne); 2022; 13():1026995. PubMed ID: 36277729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease.
    Duan S; Sun L; Zhang C; Wu L; Nie G; Huang Z; Xing C; Zhang B; Yuan Y
    Int Immunopharmacol; 2021 Apr; 93():107413. PubMed ID: 33524800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study.
    Basu M; Pulai S; Neogi S; Banerjee M; Bhattacharyya NP; Sengupta S; Mukhopadhyay P; Ray Chaudhury A; Ghosh S
    BMJ Open Diabetes Res Care; 2022 Dec; 10(6):. PubMed ID: 36517108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.
    Ren X; Wang W; Cao H; Shao F
    Front Endocrinol (Lausanne); 2023; 14():1180338. PubMed ID: 37305031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgo Biloba Extract EGB761 Ameliorates the Extracellular Matrix Accumulation and Mesenchymal Transformation of Renal Tubules in Diabetic Kidney Disease by Inhibiting Endoplasmic Reticulum Stress.
    Han J; Pang X; Shi X; Zhang Y; Peng Z; Xing Y
    Biomed Res Int; 2021; 2021():6657206. PubMed ID: 33860049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.